Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential
In the search of potent antidiabetic drug, we synthesized 1-25 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives. First, we synthesized 2-methoxybenzohydrazide from methyl 2-methoxybenzoate which was treated with different arylaldehydes to afford 1-25 compounds. The synthesized compounds wer...
Published in: | Medicinal Chemistry Research |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Birkhauser Boston
2016
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954227341&doi=10.1007%2fs00044-015-1476-8&partnerID=40&md5=3b4ae811d3f2efc065a479b4cfd60b6f |
id |
2-s2.0-84954227341 |
---|---|
spelling |
2-s2.0-84954227341 Taha M.; Ismail N.H.; Jamil W.; Imran S.; Rahim F.; Kashif S.M.; Zulkefeli M. Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential 2016 Medicinal Chemistry Research 25 2 10.1007/s00044-015-1476-8 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954227341&doi=10.1007%2fs00044-015-1476-8&partnerID=40&md5=3b4ae811d3f2efc065a479b4cfd60b6f In the search of potent antidiabetic drug, we synthesized 1-25 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives. First, we synthesized 2-methoxybenzohydrazide from methyl 2-methoxybenzoate which was treated with different arylaldehydes to afford 1-25 compounds. The synthesized compounds were evaluated for antiglycation activity. We found that 1-6 and 8 showed potent activity ranging from 160.2 to 290.17 μM better than standard drug rutin (IC50 = 295.09 ± 1.04 μM). All the synthesized compounds were characterized by different spectroscopy methods. These compounds can further be studied to develop lead antidiabetic compounds. © 2015 Springer Science+Business Media New York. Birkhauser Boston 10542523 English Article |
author |
Taha M.; Ismail N.H.; Jamil W.; Imran S.; Rahim F.; Kashif S.M.; Zulkefeli M. |
spellingShingle |
Taha M.; Ismail N.H.; Jamil W.; Imran S.; Rahim F.; Kashif S.M.; Zulkefeli M. Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
author_facet |
Taha M.; Ismail N.H.; Jamil W.; Imran S.; Rahim F.; Kashif S.M.; Zulkefeli M. |
author_sort |
Taha M.; Ismail N.H.; Jamil W.; Imran S.; Rahim F.; Kashif S.M.; Zulkefeli M. |
title |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
title_short |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
title_full |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
title_fullStr |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
title_full_unstemmed |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
title_sort |
Synthesis of 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives and evaluation of their antiglycation potential |
publishDate |
2016 |
container_title |
Medicinal Chemistry Research |
container_volume |
25 |
container_issue |
2 |
doi_str_mv |
10.1007/s00044-015-1476-8 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954227341&doi=10.1007%2fs00044-015-1476-8&partnerID=40&md5=3b4ae811d3f2efc065a479b4cfd60b6f |
description |
In the search of potent antidiabetic drug, we synthesized 1-25 2-(2-methoxyphenyl)-5-phenyl-1,3,4-oxadiazole derivatives. First, we synthesized 2-methoxybenzohydrazide from methyl 2-methoxybenzoate which was treated with different arylaldehydes to afford 1-25 compounds. The synthesized compounds were evaluated for antiglycation activity. We found that 1-6 and 8 showed potent activity ranging from 160.2 to 290.17 μM better than standard drug rutin (IC50 = 295.09 ± 1.04 μM). All the synthesized compounds were characterized by different spectroscopy methods. These compounds can further be studied to develop lead antidiabetic compounds. © 2015 Springer Science+Business Media New York. |
publisher |
Birkhauser Boston |
issn |
10542523 |
language |
English |
format |
Article |
accesstype |
|
record_format |
scopus |
collection |
Scopus |
_version_ |
1809678486686662656 |